Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide

General information
 

Name:
Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide
Size:
100 ug
Catalog no:
M2E17-P
Price:
160 EUR
 

Additional extra details
 

  • Stock availability

    Available

    Category

    Recombinant Protein

    Antibody type

    N/A

  • Antibody host

    N/A

    Antibody conjugate

    N/A

    Technical datasheet

    Contact Gentaur to request the datasheet or ask our specialists for more information.

  • Notes

    The Influenza A virus (H9N2) matrix protein 2 Control/blocking peptide is manufactured for Research Use Only or for diagnostics purposes.

    Tissue

    control

    Virus

    influenza

  • Test

    You can block the antibody by the specific target amino acid sequence of peptide.

    Properties

    blocking peptide

    Description

    Isotype or positive controls by peptides, antibodies and deactivated samples.Influenza A and B H1N1 H3N2 Hemagglutinin-nucleoprotein recombinant proteins, peptides and antibodies detect a virus commonly known as "the flu". Influenza is an infectious disease caused by an influenza virus. Symptoms can be mild to severe. The most common symptoms include a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. The cough, however, may last for more than two weeks. In children, there may be nausea and vomiting, but these are not common in adults.Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.